Global Gemtuzumab Ozogamicin Market Size In 2024: Growth Opportunities and Future Outlook 2034 Global Gemtuzumab Ozogamicin Overview:
AML is the main condition for which Global Gemtuzumab Ozogamicin Market is used as a targeted cancer therapy. It is a monoclonal antibody-drug conjugate (ADC) that mixes calicheamicin, a cytotoxic agent, with another medication. The monoclonal antibody present in gemtuzumab ozogamicin is engineered to identify and attach itself to CD33, a...
0 Compartilhamentos
87 Visualizações
0 Anterior